By Counterforce Health Team in Koselugo (selumetinib) —

How to Get Koselugo (selumetinib) Covered by Humana in Virginia: Complete Timeline and Appeals Guide

Answer Box: Fast Track to Koselugo Coverage

Koselugo (selumetinib) requires prior authorization from Humana for pediatric patients (≥2 years) with NF1 and symptomatic, inoperable plexiform neurofibromas. Standard decisions take 72 hours; expedited requests take 24 hours if life/health is at risk. Submit via CoverMyMeds or Humana's provider portal with NF1 diagnosis, imaging showing inoperable tumors, baseline cardiac (LVEF) and eye exams. If denied, you have 65 days to appeal internally, then can request Virginia Bureau of Insurance external review within 120 days.

First step today: Contact your specialist to gather NF1 documentation and submit the PA request with all required safety evaluations.

Table of Contents

What Affects Approval Timing

Several factors influence how quickly Humana approves Koselugo coverage in Virginia:

Benefit Type: Medicare Advantage and Part D plans follow federal timelines (72 hours standard, 24 hours expedited), while commercial plans may have slightly different review periods.

Documentation Completeness: Missing baseline safety evaluations (cardiac LVEF, ophthalmologic exam) or incomplete NF1 diagnosis documentation causes immediate delays for additional information requests.

Complexity of Criteria: Koselugo has specific FDA-approved indications for pediatric NF1 patients with symptomatic, inoperable plexiform neurofibromas. Cases outside these parameters require more extensive medical necessity review.

Reviewer Familiarity: Rare disease medications like Koselugo may require specialist review within Humana's medical team, potentially adding 1-2 business days to standard timelines.

Pre-Submission Prep (0-2 Days)

Essential Documentation Checklist

Before submitting your prior authorization request, gather these required documents:

Diagnosis Documentation:

  • Confirmed NF1 diagnosis (genetic testing, clinical criteria, or imaging)
  • Recent MRI or CT showing plexiform neurofibromas
  • Documentation of symptoms (pain, functional impairment, disfigurement)
  • Surgical consultation notes confirming inoperability

Safety Evaluations:

  • Baseline LVEF assessment via echocardiogram or MUGA scan (≥50-55%)
  • Comprehensive ophthalmologic examination documenting no retinal issues
  • Complete blood count and comprehensive metabolic panel

Administrative Requirements:

  • Current Humana insurance card and member ID
  • Prescriber information (DEA, NPI, specialty)
  • Patient demographics and contact information
Tip: Contact Alexion's OneSource program for PA support and pre-populated forms with patient consent.

Submission to Initial Review (1-5 Days)

Fastest Submission Methods

Electronic Submission (Recommended):

Alternative Methods:

  • Fax: Use Humana's PA fax number (verify current number via provider portal)
  • Phone: Call the number on your insurance card for urgent cases

What Reviewers Check First

Humana's initial review focuses on:

  1. FDA Indication Match: Patient age ≥2 years with confirmed NF1
  2. Symptomatic Disease: Documentation of pain, functional impairment, or cosmetic concerns
  3. Inoperability: Surgical consultation or imaging-based assessment
  4. Safety Prerequisites: Baseline cardiac and ophthalmologic evaluations completed
  5. Prescriber Qualifications: Oncologist, neurologist, or specialist with NF1 experience

Decision Window and Outcomes

Standard Timeline Expectations

Review Type Humana Decision Time Virginia Rights
Standard PA 72 hours Internal appeal within 65 days
Expedited PA 24 hours Expedited appeal available
Formulary Exception 72 hours Standard appeal process

Reading Your Approval Letter

Approved: Look for specific quantity limits, refill restrictions, and renewal requirements. Most approvals are for 12 months with reauthorization required.

Conditional Approval: May require additional monitoring or dose adjustments based on response and safety parameters.

Partial Approval: Coverage for a shorter duration pending additional clinical data or safety evaluations.

If Denied: Virginia Appeals Process

Internal Appeals with Humana

Timeline: File within 65 days of denial notice Decision: 30 days (72 hours if expedited) How to File:

Virginia Bureau of Insurance External Review

After exhausting Humana's internal process, Virginia residents can request external review:

Eligibility: Medical necessity denials, experimental treatment determinations Timeline: File within 120 days of final internal denial Process: Submit Form 216-A to Virginia Bureau of Insurance

Contact Information:

  • Email: [email protected]
  • Phone: 1-877-310-6560
  • Address: State Corporation Commission, Bureau of Insurance – External Review, P.O. Box 1157, Richmond, VA 23218

Decision Timeline:

  • Standard review: 45 days
  • Expedited review: 72 hours (if provider certifies serious health jeopardy)
Note: Virginia's external review is binding on Humana and provided at no cost to patients.

Renewal Cycles and Re-Authorization

When to Start Renewal Process

Begin reauthorization 30-45 days before your current approval expires. Most Koselugo approvals require renewal every 12 months.

What Speeds Up Renewals

Clinical Response Documentation:

  • Updated imaging showing tumor volume changes
  • Functional improvement assessments
  • Pain or quality of life measurements

Safety Monitoring Results:

  • Current LVEF assessment (if stable, may not need repeat echo)
  • Ophthalmologic exam results
  • Laboratory values and adverse event documentation

What Changes Speed Renewals: Stable disease with good tolerance typically processes faster than cases requiring dose modifications or managing significant side effects.

Timeline Visual and Milestones

Milestone Timeline Key Actions
Preparation Days 0-2 Gather NF1 docs, safety evals, insurance info
Submission Days 1-2 Submit via CoverMyMeds or provider portal
Initial Review Days 3-5 Humana medical team reviews criteria
Decision Day 5-7 Approval, denial, or request for more info
If Additional Info Days 8-12 Respond within 14 days to avoid denial
Final Decision Days 13-15 Coverage determination issued
Appeal (if denied) Days 16-80 Internal appeal within 65 days
External Review Days 81-200 Virginia BOI review within 120 days

Time-Saving Tips

Portal Usage Best Practices

Use Humana's PA Search Tool to verify current requirements before submitting.

Bundle Evidence: Submit all required documents simultaneously rather than piecemeal responses to information requests.

Direct Specialty Routing: Ensure your prescriber is listed as an oncologist or neurologist in Humana's system for faster routing to appropriate reviewers.

Electronic Submission Advantages

Electronic submissions through CoverMyMeds or the provider portal offer:

  • Real-time status tracking
  • Immediate confirmation of receipt
  • Automated routing to correct review teams
  • Faster processing than fax or mail

Common Denial Reasons & Fixes

Denial Reason How to Overturn Required Documents
Missing NF1 diagnosis Submit genetic testing or clinical criteria documentation NF1 diagnostic criteria, imaging reports
Age outside indication Confirm patient ≥2 years; for adults, consider mirdametinib alternative Birth certificate, current age verification
Missing baseline safety evals Complete LVEF and ophthalmologic exams before resubmission Echo/MUGA results, eye exam report
Insufficient symptom documentation Provide detailed functional assessment and pain scores Clinical notes, quality of life measures
Non-formulary status Request formulary exception with medical necessity letter Formulary exception form

Appeals Playbook for Humana in Virginia

Level 1: Internal Appeal

Who Can File: Patient, authorized representative, or prescriber Deadline: 65 days from denial notice Methods:

  • Online via member portal
  • Phone: 1-800-867-6601
  • Fax: Number provided in denial letter

Required Information:

  • Member ID and denial reference number
  • Specific reasons for disagreement with denial
  • Additional clinical documentation
  • Updated medical necessity letter

Level 2: Virginia External Review

Eligibility: After completing internal appeals process Deadline: 120 days from final internal denial Cost: Free to Virginia residents Decision: Binding on Humana

Expedited Process Available: If provider certifies delay could seriously jeopardize health

From our advocates: "We've seen many successful Koselugo appeals when families submit comprehensive symptom documentation alongside the required safety evaluations. The key is showing how the medication addresses specific functional limitations caused by the plexiform neurofibromas, not just their presence on imaging."

FAQ

How long does Humana PA take in Virginia? Standard prior authorization decisions are made within 72 hours. Expedited requests for urgent medical situations receive decisions within 24 hours.

What if Koselugo is non-formulary on my Humana plan? You can request a formulary exception by demonstrating medical necessity. Submit evidence that formulary alternatives are ineffective or cause adverse effects.

Can I request an expedited appeal in Virginia? Yes, if your provider certifies that waiting for standard review timelines could seriously jeopardize your life, health, or ability to regain function.

Does step therapy apply to Koselugo? Step therapy requirements vary by plan. Check your specific formulary or contact Humana to verify if you must try other treatments first.

What happens if Virginia external review upholds the denial? The external review decision is final and binding. You may still have options through employer appeals (for self-funded plans) or legal consultation.

How much does Koselugo cost without insurance? Cash prices range from approximately $2,651 (28×10mg capsules) to $6,617 (28×25mg capsules), with annual costs potentially exceeding $268,000 depending on dosing requirements.

Are there patient assistance programs available? Yes, AstraZeneca offers patient support programs including financial assistance for eligible patients.

What documentation do I need for renewal? Updated imaging, safety monitoring results (cardiac and ophthalmologic), clinical response assessment, and any adverse event documentation.

About Counterforce Health

Counterforce Health specializes in turning insurance denials into successful appeals for specialty medications like Koselugo. Our platform analyzes denial letters, identifies specific coverage criteria, and generates evidence-backed appeals that address payer requirements point-by-point. We help patients, clinicians, and specialty pharmacies navigate complex prior authorization processes with targeted documentation and procedural expertise.

For additional support with your Koselugo coverage journey, Counterforce Health provides comprehensive appeal assistance tailored to your specific payer and state requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider regarding treatment decisions and contact Virginia's Bureau of Insurance or a qualified attorney for specific legal guidance on insurance appeals.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.